Significantly, individual types of cancer typically associate with particular lesions in this network (e.g., mutation of RB1 in retinoblastoma, mutation of INK4A in pancreatic cancer, amplification of Cyclin D1 in breast tumors, etc.). This evidence concerns the gene CDKN2A and cancer.